| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 81295-21-8 | Restriction Endodeoxyribo-Nuclease HincII | |
| 81295-22-9 | Endodeoxyribonuclease Hind III | |
| 81295-23-0 | Restriction endodeoxyribonuclease Hinf I | |
| 81295-24-1 | Restriction endodeoxyribonuclease Hpa I | |
| 81295-25-2 | Restriction endodeoxyribonuclease Hpa II | |
| 81295-27-4 | Restriction endodeoxyribonuclease Kpn I | |
| 81295-28-5 | Restriction endodeoxyribonuclease CacI | |
| 81295-29-6 | Restriction endonuclease Mbo II | |
| 81295-32-1 | Restriction endodeoxyribonuclease Pst I | |
| 81295-33-2 | Restriction endodeoxyribonuclease Pvu I | |
| 81295-34-3 | Restriction endonuclease Pvu II | |
| 81295-35-4 | Endodeoxyribonuclease Sac I | |
| 81295-36-5 | Restriction endodeoxyribonuclease Ksp I | |
| 81295-38-7 | Restriction endodeoxyribonuclease Sal I | |
| 81295-40-1 | Endodeoxyribonuclease Taq I | |
| 81295-42-3 | Endodeoxyribonuclease Xba I | C97H123N38O58P9 |
| 81295-43-4 | Endodeoxyribonuclease Xho I | |
| 81295-45-6 | Endodeoxyribonuclease Xma I | |
| 81302-80-9 | 2-[(Trimethylsilyl)methyl]-2-propen-1-ol | C7H16OSi |
| 81303-52-8 | 5-(Aminocarbonyl)-1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester | C8H11N3O3 |
| 81303-57-3 | 3-Cyano-1-methyl-1H-pyrazole-4-carboxylic acid | C6H5N3O2 |
| 81303-58-4 | 3-Cyano-1-methyl-1H-pyrazole-4-carbonyl chloride | C6H4ClN3O |
| 81303-59-5 | 5-Cyano-1-methyl-1H-pyrazole-4-carboxylic acid | C6H5N3O2 |
| 81303-60-8 | 5-Cyano-1-methyl-1H-pyrazole-4-carbonyl chloride | C6H4ClN3O |
| 81303-65-3 | 1-Methyl-1H-pyrazole-4,5-dicarboxylic acid 4-ethyl ester | C8H10N2O4 |
| 81303-69-7 | Cyclopentanecarboximidamide | C6H12N2 |
| 81304-51-0 | (E)-1-(5-Methyl-1,3-Dioxan-5-Yl)-2-(1,2,4-Triazol-1-Yl)-3-[4-(Trifluoromethyl)Phenyl]Prop-2-En-1-Ol | C17H18F3N3O3 |
| 81305-72-8 | 2,6-Dichloro-1,4-dihydro-3,5-pyridinedicarboxaldehyde | C7H5Cl2NO2 |
| 81305-87-5 | 4-Amino-2-methyl-3,5-pyridinedicarbonitrile | C8H6N4 |
| 81306-52-7 | Halocynthiaxanthin | C40H54O4 |
| 81306-64-1 | Parathyroid Hormone Fragment (13-34) (Human) | C125H199N39O33S |
| 81306-93-6 | N-[(1,1-Dimethylethoxy)carbonyl]-3-[[(phenylmethoxy)carbonyl]amino]-D-alanine | C16H22N2O6 |
| 81306-94-7 | N-Boc-N'-Cbz-D-2,3-diaminopropionic acid dicyclohexylamine salt | C16H22N2O6.C12H23N |
| 81307-09-7 | 3-Methoxy-4-(4-Nitrobenzyloxy)Benzaldehyde | C15H13NO5 |
| 81307-24-6 | (11aS)-7-Methoxy-8-Hydroxy-2,3,5,11ab-Tetrahydro-1H-Pyrrolo[2,1-c][1,4]Benzodiazepine-5-One | C13H14N2O3 |
| 81307-43-9 | Antibiotic F2 triacetate | C38H46O11 |
| 81308-36-3 | Methyl N-(benzyloxy)-N-methoxy-2-methylalaninate | C13H19NO4 |
| 81309-33-3 | 21-Hydroxy-3,20-dioxopregn-4-en-19-oic acid | C21H28O5 |
| 81310-19-2 | (2S,5S)-3,3-Dimethyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carbaldehyde | C9H13NO2 |
| 81310-56-7 | 1-(Piperidin-3-Ylmethyl)Piperidine | C11H22N2 |
| 81310-58-9 | 4-(2-Piperidinylmethyl)morpholine | C10H20N2O |
| 81310-60-3 | 4-(3-Piperidinylmethyl)morpholine | C10H20N2O |
| 81311-33-3 | N,2-Dicyclohexyl-2-Phenethylamine | C20H31N |
| 81311-95-7 | trans-3-Furanacrylic Acid | C7H6O3 |
| 81313-42-0 | 1,4-Anhydroerythritol | C4H8O3 |
| 81316-68-9 | 2,6-Dichloro-5-ethyl-4-pyrimidinamine | C6H7Cl2N3 |
| 81316-80-5 | 3-Nitrobenzo(k)Fluoranthene | C20H11NO2 |
| 81316-84-9 | 1-Nitrocoronene | C24H11NO2 |
| 81316-87-2 | 5-Nitrobenzo(ghi)Perylene | C22H11NO2 |
| 81319-48-4 | (1S,3S,4S,4aS,6aS,7E,10S,11E,12aR,13S,16aS,20aS,20bR)-13-(acetyloxy)-1,2,3,4,4a,6a,9,10,12a,13,16,20,20a,20b-tetradecahydro-4,21-dihydroxy-1,3,7,11,20a-pentamethyl-18,20-dioxo-10-[[2,3,4,6-tetradeoxy-4-[(methoxycarbonyl)amino]-3-C-methyl-3-nitro-beta-D-xylo-hexopyranosyl]oxy]-18H-16a,19-metheno-16aH-benzo[b]naphth[2,1-j]oxacyclotetradecin-15-carboxaldehyde | C43H56N2O14 |